Esophageal and Gastroesophageal Junction Carcinoma

Esophageal and Gastroesophageal Junction Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,309 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 460
Recruiting: 254
Ph III recruiting: 40
Growth YoY: +36.1%
Industry share: 22%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (120)

clinicaltrialsPublishedShowing 151–155 of 155 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01605305	Study on FOLFOX6 as First-line Therapy to Treat Recurrent or Metastatic Esophageal Cancer	completed	Phase 2	60	Fudan UniversityOTHER	0	May 24, 2012	clinicaltrials
NCT00411151	Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer	completed	Phase 2	52	Johannes Gutenberg University MainzOTHER	1	Jan 20, 2011	clinicaltrials